Build your own keyword analysis with our tools
SEO Report
Server Infos
Backlinks

HTML Analysis

Page Status
 

Found

Highlighted Content
Title

Male Hypogonadism Treatment, Low T - AXIRON (testosterone) topical solution

Description

AXIRON topical solution is a testosterone therapy applied to the underarm. Learn how AXIRON may treat your patients with male hypogonadism (low testosterone).

Keywords

male hypogonadism, low t, AXIRON, topical solution, testosterone therapy, low testosterone

H1

Indication
Important Safety Information for AXIRON
Indication
Important Safety Information
Important Safety Information for AXIRON (testosterone) topical solution
You are now leaving the AxironMD.com Web site

H2

WARNING: SECONDARY EXPOSURE TO TESTOSTERONE
CONTRAINDICATIONS
WARNINGS AND PRECAUTIONS
DRUG INTERACTIONS
USE IN SPECIFIC POPULATIONS
ADVERSE REACTIONS
WARNING: SECONDARY EXPOSURE TO TESTOSTERONE
CONTRAINDICATIONS
WARNINGS AND PRECAUTIONS
DRUG INTERACTIONS
USE IN SPECIFIC POPULATIONS
ADVERSE REACTIONS

H3

AXIRON is contraindicated in:
Strict adherence to the following precautions is advised to minimize the potential for secondary exposure to testosterone from the skin:
AXIRON is contraindicated in:
Strict adherence to the following precautions is advised to minimize the potential for secondary exposure to testosterone from the skin:

H4

H5

home

Text Analysis

Cloud of Keywords from all content
High relevance
 

axiron patients testosterone application cancer risk children including increased exposure treatment secondary contact androgens prostate water women therapy hematocrit cases serum disease safety soap unclothed virilization concentrations adverse unwashed avoid increase pregnant reactions insulin signs precautions t-shirt topical recommended warning sites hair occur lilly hypogonadism clinical

Medium relevance
 

sleep renal gynecomastia apnea hepatic solution cardiac bph decrease globulin included return initiation hypercalcemia development monitoring libido decreased pubic months re-evaluate products thyroid transfer woman size dose initiating concentration treated symptoms discontinuation exposed prior edema company gonadotropins dried geriatric insufficient failure androgen males congenital acquired spermatogenesis syndrome applied conditions deficiency effects retention range years advised bone reported boxed wash efficacy require corticosteroids hormone study medication prescribing control healthcare guide

Low relevance
 

study medication prescribing control healthcare guide annually level hypercalciuria thromboembolic check elevated starting decreases caution acceptable adjustment chronic persist promote count sperm develop sodium pre-existing complication heart congestive potentiate factors profile lead suppressed doses lipid semen obesity parameters lipids events drug younger differs pivotal long-term assess data determine studies fluid acth monitored cautiously numbers populations incremental cardiovascular pv8151 10aug2011 privacy axironmd responsible web hcp psa irritation common erythema headache vomiting diarrhea termination anticoagulants evidence unchanged dysfunction flammability flame smoking remain free thyroxine-binding calcium thyroxin-binding total uptake resin interactions sensitivity anticoagulant anti-coagulants activity frequent prothrombin inr oral requirements diabetic glycemic metabolic blood glucose regular clothing lowering advise adhere instructions contraindicated contraindications providers secondarily radiation trauma limitations established breast suspected fetus hazard warnings benign hyperplasia prostatic apprised infants fetal breastfeeding harm administered nursing tumors injury torsion bilateral orchitis vanishing orchiectomy testis cryptorchidism testicular replacement indication absence endogenous primary klinefelter chemotherapy gonadotropin idiopathic luteinizing hormone-releasing pituitary-hypothalamic lhrh hypogonadotropic fsh damage toxic alcohol heavy metals monitor strictly situation cover skin-to-skin anticipated residue remove hands minimize discontinued physician identified strict adherence event general surface removed washing polycythemia increases residual majority washed area interpersonal worsening wearing attention reduced behavior aggressive advanced regressed enlarged removal erections clitoris evaluate brought screening practices enlargement genitalia penis genital inappropriate acne adult possibility age-appropriate product distribution remained adhering modestly greater chronological

Very Low relevance
 
annually level hypercalciuria thromboembolic check elevated starting decreases caution acceptable adjustment chronic persist promote count sperm develop sodium pre-existing complication heart congestive potentiate factors profile lead suppressed doses lipid semen obesity parameters lipids events drug younger differs pivotal long-term assess data determine studies fluid acth monitored cautiously numbers populations incremental cardiovascular pv8151 10aug2011 privacy axironmd responsible web hcp psa irritation common erythema headache vomiting diarrhea termination anticoagulants evidence unchanged dysfunction flammability flame smoking remain free thyroxine-binding calcium thyroxin-binding total uptake resin interactions sensitivity anticoagulant anti-coagulants activity frequent prothrombin inr oral requirements diabetic glycemic metabolic blood glucose regular clothing lowering advise adhere instructions contraindicated contraindications providers secondarily radiation trauma limitations established breast suspected fetus hazard warnings benign hyperplasia prostatic apprised infants fetal breastfeeding harm administered nursing tumors injury torsion bilateral orchitis vanishing orchiectomy testis cryptorchidism testicular replacement indication absence endogenous primary klinefelter chemotherapy gonadotropin idiopathic luteinizing hormone-releasing pituitary-hypothalamic lhrh hypogonadotropic fsh damage toxic alcohol heavy metals monitor strictly situation cover skin-to-skin anticipated residue remove hands minimize discontinued physician identified strict adherence event general surface removed washing polycythemia increases residual majority washed area interpersonal worsening wearing attention reduced behavior aggressive advanced regressed enlarged removal erections clitoris evaluate brought screening practices enlargement genitalia penis genital inappropriate acne adult possibility age-appropriate product distribution remained adhering modestly greater chronological influence conent consumers solely maintained link dosing endorse clicked party visit click continue patient proceed policy attributed claims comments expressed opinions home axironmd advanced indianapolis talking map resources insert package male safetyinformation reference statement terms professionals united ts81953 intended reserved copyright llc rights leaving

Highlighted Content Analysis

Cloud of Keywords from all content
High relevance
 

testosterone axiron

Medium relevance
 

precautions exposure secondary safety topical solution

Low relevance
 

safety topical solution populations interactions hypogonadism warnings drug reactions advised minimize adherence strict contraindicated adverse contraindications indication warning male

Very Low relevance
 
populations interactions hypogonadism warnings drug reactions advised minimize adherence strict contraindicated adverse contraindications indication warning male low t therapy male hypogonadism testosterone therapy low testosterone applied topical solution treat axironmd web leaving patients learn treatment underarm